Chargement en cours...
Assessing the cost-effectiveness of pharmacogenomics
The use of pharmacogenomics to individualize drug therapy offers the potential to improve drug effectiveness, reduce adverse side effects, and provide cost-effective pharmaceutical care. However, the combinations of disease, drug, and genetic test characteristics that will provide clinically useful...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Springer-Verlag
2000
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761139/ https://ncbi.nlm.nih.gov/pubmed/11741245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/ps020329 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|